Reacción #1140

ord-90e66e44000e45b397f6a1aa0fe837fd

Ecuación de reacción

CN1C(=O)C(Br)(Br)CC1c1cncc(Br)c1
5-bromo-3-(3,3-dibromo-1-methyl-5-pyrrolidin-2-onyl)pyridine
[Te]
tellurium
[BH4-].[Na+]
Sodium borohydride
CCOC(C)=O
ethyl acetate
CN1C(=O)CCC1c1cncc(Br)c1
5-bromo-3-(1-methyl-5-pyrrolidin-2-onyl)pyridine
Rendimiento 68.0%

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    TemperaturaThe mixture was heated
  2. 2
    Temperaturaunder reflux for 0.25 h
  3. 3
    Filtraciónthe solution was filtered through Celite
  4. 4
    Concentraciónconcentrated in vacuo
  5. 5
    workup.ADDITION1M HCl (10 mL) was added to the residue
  6. 6
    ExtracciónAfter extraction with ethyl acetate (50 mL) the organic phase
  7. 7
    Otrowas separated
  8. 8
    ExtracciónThe aqueous phase was extracted with ethyl acetate (2×50 mL)
  9. 9
    Lavadothe combined organic phases were washed with brine (30 mL)
  10. 10
    Secadodried (MgSO4)
  11. 11
    Concentraciónconcentrated
  12. 12
    OtroThis material was chromatographed on silica gel with ethyl acetate:hexane (1:1) as eluant

Procedimiento

Sodium borohydride (862 mg, 22.8 mmol) was dissolved in ethanol (20 mL) and tellurium metal powder (1.45 g, 11.4 mmol) was added in portions. The mixture was heated under reflux for 0.25 h and 5-bromo-3-(3,3-dibromo-1-methyl-5-pyrrolidin-2-onyl)pyridine (775 mg, 1.9 mmol) was added to the solution at 25° C. After stirring for 2 h, ethyl acetate (50 mL) was added and the solution was filtered through Celite and concentrated in vacuo. 1M HCl (10 mL) was added to the residue and the solution was adjusted to pH 11 with solid potassium carbonate. After extraction with ethyl acetate (50 mL) the organic phase was separated. The aqueous phase was extracted with ethyl acetate (2×50 mL) and the combined organic phases were washed with brine (30 mL), dried (MgSO4) and concentrated. This material was chromatographed on silica gel with ethyl acetate:hexane (1:1) as eluant to afford 5-bromo-3-(1-methyl-5-pyrrolidin-2-onyl)pyridine as a solid (329 mg, 68%). M.p. 85°-87° C.; 1H NMR (CDCl3, 300 MHz): δ 8.66 (d, J=2 Hz, 1H), 8.42 (d, J=2 Hz, 1H), 7.68 (t, J=2 Hz, 1H), 4.56 (t, J=7 Hz, 1H), 2.71 (s, 3H), 2.45-2.65 (m, 2H), 1.80-1.95 (m, 2H).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US05723477uspto-grants-1998_03